Understand the support services available to ALK+ #LungCancer patients and how patients can better advocate for themselves and live with the emotional impacts of being diagnosed.
Developed and funded by Pfizer Ltd. Intended for UK patients diagnosed with ALK+ NSCLC and Healthcare Professionals (HCPs) included in their treatment. This is for educational purposes only and not intended to replace a HCP’s advice. The views and opinions expressed in this programme are those of the speakers and do not necessarily reflect the views or positions of Pfizer Ltd.
If you enjoyed listening here today, you might like the Pfizer UK podcast channel: https://www.pfizer.co.uk/news/podcasts
PP-UNP-GBR-7814 / April 2024